✦ LIBER ✦

Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection

✍ Scribed by Raghini Ranganathan; Krishnaveni Janarthanan; Senthilkumar Rajasekaran

Book ID: 117689918
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 129 KB
Volume: 2
Category: Article
ISSN: 0973-6883
DOI: 10.1016/s0973-6883(12)60089-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferon and ribavirin thera

Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection

✍ F. Legrand-Abravanel; F. Nicot; A. Boulestin; K. Sandres-Sauné; J.P. Vinel; L. A 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract Hepatitis C Virus (HCV) is classified into six genotypes. Genotype 4 is now spreading in Europe, especially among drug users, who are often infected with both HCV and the human immunodeficiency virus (HIV). Previous studies have shown that HCV‐4 responds poorly to interferon. Pegylated

Development of type 1 diabetes mellitus

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

✍ Fabris, P.; Floreani, A.; Lazzari, F.De; Betterle, C.; Greggio, N.A.; Naccarato, 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 164 KB

1190 Diabetes mellitus of new onset duri

1190 Diabetes mellitus of new onset during pegylated interferon and ribavirin therapy for chronic hepatitis C: observations from the WIN-R trial

✍ AHMED, F; JACOBSON, I; HARGRAVE, T; LAWITZ, E; MIGICOVSKY, B; REDDY, V; TERRAULT 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Dual onset of type 1 diabetes mellitus a

Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C

✍ Masayuki Hayashi; Yuko Kataoka; Kazushige Tachikawa; Hiroki Koguchi; Hiroshi Tan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Exacerbation of type 2 diabetes mellitus

Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B

✍ E.P.A. Lopes; P.M. Oliveira; A.E. Silva; M.L. Ferraz; C.H.R.M. Costa; W. Miranda 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 151 KB

High incidence of type 1 diabetes mellit

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

✍ Tim C. M. A. Schreuder; Huub C. Gelderblom; Christine J. Weegink; Dörte Hamann; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB